Zhang, H., Zhang, H., Zhang, H., He, H., Feng, Q., Wu, B., . . . Lin, J. Higher 3-year recurrence-free survival rate in patients with complete pathological remission following neoadjuvant chemotherapy plus immunotherapy for esophageal cancer: A two-center, propensity score matching study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationZhang, Hai, et al. Higher 3-year Recurrence-free Survival Rate in Patients with Complete Pathological Remission Following Neoadjuvant Chemotherapy Plus Immunotherapy for Esophageal Cancer: A Two-center, Propensity Score Matching Study. Frontiers Media S.A.
MLA (9th ed.) CitationZhang, Hai, et al. Higher 3-year Recurrence-free Survival Rate in Patients with Complete Pathological Remission Following Neoadjuvant Chemotherapy Plus Immunotherapy for Esophageal Cancer: A Two-center, Propensity Score Matching Study. Frontiers Media S.A.